Tag: News Releases


Chyka Appointed Associate Dean of UT College of Pharmacy in Knoxville

|

Effective January 1, Peter A. Chyka, PharmD, was appointed associate dean of the College of Pharmacy’s Knoxville campus. Dick R. Gourley, PharmD, professor and dean of the UTHSC College of Pharmacy, announced the appointment.


Congress Appropriates $2 Million to UTHSC Initiatives

|

The UT Cancer Institute and the UT Rapid Biopathogen Detection Technology Program, two of UTHSC’s most dynamic initiatives, will each receive $1 million as part of the Fiscal Year 2006 Defense Appropriations bill.


Briggs Gift Allows Eye Institute to Begin Diabetic Retinopathy Program

|

Thanks to a three-year $150,000 grant from the Thomas W. Briggs Foundation, UTHSC’s Hamilton Eye Institute can develop a program to help patients who suffer from diabetic retinopathy.


UTHSC Hosts Foreign Fulbright Scholar

|

The University of Tennessee Health Science Center (UTHSC) has been selected to host Fulbright Visiting Scholar Mark Joseph Walker, PhD, from the University of Wollongong, Australia, for part of the 2005-2006 academic year.


UTHSC Research and Patient Care Enhanced Thanks to FedEx Gift

|

FedEx Corporation has contributed $250,000 to the UT Hamilton Eye Institute and $250,000 to the UT Cancer Institute. Both recipients, part of the UTHSC College of Medicine, will receive the gifts over the next three years.


UTHSC Investigator Selected for Lupus Research Grant

|

Marko Z. Radic, PhD, associate professor in the Department of Molecular Sciences at UTHSC, was among a select few researchers to be chosen for a Lupus Research Institute (LRI) grant.


UTHSC Professor Awarded Grants to Explore Retinal Degeneration

|

Monica M. Jablonski, PhD, associate professor of ophthalmology at the UTHSC Hamilton Eye Institute, has been awarded a three-year $428,800 National Institutes of Health (NIH) grant to research retinal degeneration.


UTHSC Scientist Receives NIH Grant to Pursue Liver Cancer Research

|

Lakita Cavin, PhD, assistant professor in the Department of Pharmacology, has been awarded a nearly $600,000 National Institutes of Health (NIH) grant to study the role of various genes involved in liver cancer.